Demo Sign up Log In

Inhibikase Therapeutics Inc (IKT)

P/OCF Ratio

-6.53×

TTM · Retrieved: Oct 22, 2026

IKT P/OCF Ratio

Current (TTM)-6.53×retrievedOct 22, 2026

Current (TTM)-6.53×retrievedOct 22, 2026

IKT Quarterly P/OCF Ratio (820.34× → -28.48×)

Latest values, visible window

High-resolution chart · PNG

IKT p/ocf ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Inhibikase Therapeutics Inc P/OCF Ratio — Quarterly
Period ending	P/OCF Ratio
Jun 30, 2026	-28.4789×
Mar 31, 2026	-24.0035×
Dec 31, 2025	-25.688×
Sep 30, 2025	-13.772×
Jun 30, 2025	-31.4875×
Mar 31, 2025	-47.7848×
Dec 31, 2024	-9.9085×
Sep 30, 2024	-2.3657×
Jun 30, 2024	-1.8487×
Mar 31, 2024	-3.5417×
Dec 31, 2023	-2.2823×
Sep 30, 2023	-1.8089×
Jun 30, 2023	-4.1324×
Mar 31, 2023	-3.0326×
Dec 31, 2022	-3.5467×
Sep 30, 2022	-4.1703×
Jun 30, 2022	-4.3051×
Mar 31, 2022	-9.482×
Dec 31, 2021	-9.0557×
Sep 30, 2021	-23.6441×
Jun 30, 2021	-8.0719×
Mar 31, 2021	-15.3586×
Dec 31, 2020	-60.4097×
Sep 30, 2020	1,074.8549×
Jun 30, 2020	-7,592.2041×
Mar 31, 2020	-317.1067×
Dec 31, 2019	12,708.5056×
Sep 30, 2019	-11,908.7349×
Jun 30, 2019	-1,648.1735×
Mar 31, 2019	-280.5168×
Dec 31, 2018	0×
Mar 31, 2018	1,207.0325×
Dec 31, 2017	0×
Mar 31, 2017	820.3377×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.